Neurocrine Biosciences, Inc <NBIX.O>: Wedbush raises target price to $194 from $185
NBIX•Related News
RH: BofA Global Research reinstates coverage with Underperform rating; price objective $156
RH•
Cleanspark Inc <CLSK.O>: B. Riley Raises Target Price to $26 From $19
CLSK•
Idaho Copper names Ryan Mauser director of technical studies
COPR•
Veru schedules conference call on quarterly financial results and business update
VERU•
AB InBev-commissioned whitepaper flags moderation trend as alcohol market stays resilient
BUD•